MD
Veradigm Inc.
MDRX · OTC
$4.85 +3.19% (+$0.15)
1M -4.08%
Market Cap $862.7M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
5/9Valuation
88 /100
Cheap P/B 0.85x
EV/EBITDA 10.88x
P/FCF 10.36x
Growth
0 /100
Declining Book val. growth 7.49%
Rev. growth 28.85%
FCF growth N/A
Profitability
45 /100
Moderate Op. margin 4.61%
Gross margin 52.45%
FCF margin 14.17%
Quality
7 /100
Poor Asset turnover 0.39x
ROIC 0.66%
ROA 5.75%
Debt
80 /100
Low Int. coverage -9.05x
Debt/Equity 0.22x
Net debt/EBITDA -3.89x
Stability
29 /100
Unstable EPS volatility 360.10%
Beta 0.56x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MDRX
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Donald D. Trigg
Employees
2,300
Headquarters
Chicago
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report